Skip to main content

Table 2 Direct healthcare costs of hospitalizations in patients with RSV infection and weighted mean cost of each wheezing exacerbation in Colombia, 2022

From: Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia

Parameter

Direct healthcare costs (USD)

Ref

Cost of each RSV-related hospitalization in preterm neonates and infants with BPD.

$ 2,076

[12]

Cost of each RSV-related hospitalization in infants with CHD.

$ 3,772

[12, 13]

The weighted mean cost of each wheezing exacerbation (outpatient, ER, or hospitalization).

$ 174

[14]